Last reviewed · How we verify
HRS-5346 tablets — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
HRS-5346 tablets (HRS-5346 tablets) — Shandong Suncadia Medicine Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HRS-5346 tablets TARGET | HRS-5346 tablets | Shandong Suncadia Medicine Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HRS-5346 tablets CI watch — RSS
- HRS-5346 tablets CI watch — Atom
- HRS-5346 tablets CI watch — JSON
- HRS-5346 tablets alone — RSS
Cite this brief
Drug Landscape (2026). HRS-5346 tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/hrs-5346-tablets. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing